CODEX+ CELIDA Recommendations
1.5.2 - ci-build

CODEX+ CELIDA Recommendations - Local Development build (v1.5.2) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

PlanDefinition: Antithrombotic prophylaxis with Fondaparinux (Experimental)

Official URL: https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/intervention-plan/antithrombotic-prophylaxis-fondaparinux Version: 0.1
Active as of 2022-04-27 Responsible: NUM CODEX+ CELIDA Computable Name: AntithromboticProphylaxisWithFondaparinux

Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients

Generated Narrative: PlanDefinition AntithrombFondapProphInHospitalisedCOVID19PatientsRecommPlan

url: PlanDefinition Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients

version: 0.1

name: AntithromboticProphylaxisWithFondaparinux

title: Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients

type: ECA Rule

status: Active

experimental: true

subject: Population: Hospitalised COVID-19 patients with existing contraindications to LWMH

date: 2022-04-27

publisher: NUM CODEX+ CELIDA

description:

Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients

action

code: Administration of substance (procedure)

definition: Antithrombotic prophylaxis with Fondaparinux

action

code: Administration of substance (procedure)

definition: NO Therapeutic Anticoagulation Treatment with Fondaparinux